Oral Microbiota and Host Immune System

The oral microbiota and host immune system represent a complex, bidirectional relationship essential for maintaining both local and systemic health. The oral cavity is home to one of the most diverse microbial communities in the human body, which interacts continuously with the host's mucosal immune cells to maintain a state of symbiotic homeostasis. This interaction involves the recognition of microbial-associated molecular patterns (MAMPs) by host pattern recognition receptors (PRRs), which calibrates the immune response to tolerate commensals while remaining vigilant against pathogens. (Source: Nature Reviews Immunology, 2015; NIH/NIDCR). When this delicate balance is disrupted—a state known as dysbiosis—it can lead to the overgrowth of keystone pathogens like Porphyromonas gingivalis, which subvert the host immune response to promote an inflammatory environment. This chronic inflammation is the hallmark of periodontal disease and has been significantly linked to systemic conditions such as cardiovascular disease, rheumatoid arthritis, and diabetes through the hematogenous spread of bacteria and inflammatory mediators. (Source: Journal of Oral Microbiology, 2020; Frontiers in Immunology, 2021). Pharmacological strategies targeting this system include the use of antimicrobials to manage bacterial load and host-modulatory agents to limit tissue destruction caused by the immune system's own inflammatory cascade.

Other names

Oral microbiome-immune axisOral commensal-host interactionOral microbiota-host immunityOral-systemic health axis

Therapeutic intervention involves the use of broad-spectrum or targeted antimicrobials to reduce pathogen load, probiotics to restore commensal balance through competitive exclusion, and host-modulatory therapies to dampen excessive inflammatory responses (e.g., sub-antimicrobial dose doxycycline).